PEPG
PepGen Ltd
NASDAQ: PEPG · HEALTHCARE · BIOTECHNOLOGY
$1.55
-1.90% today
Updated 2026-04-29
Market cap
$109.20M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.12
Dividend yield
—
52W range
$1 – $8
Volume
1.5M
PepGen Ltd (PEPG) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — |
| Cost of revenue | $106000.00 | $110000.00 | $178000.00 | $493000.00 | $1.18M | $1.50M | $1.40M |
| Gross profit | $-106000.00 | $-110000.00 | $-178000.00 | $-493000.00 | $-1.18M | $-1.50M | $-1.40M |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $620000.00 | $1.12M | $23.80M | $54.08M | $68.13M | $76.48M | $71.04M |
| SG&A | $628000.00 | $853000.00 | $8.11M | $14.22M | $16.64M | $21.26M | $22.57M |
| Operating income | $-1.35M | $-1.88M | $-27.11M | $-68.30M | $-84.77M | $-97.74M | $-93.61M |
| Operating margin | — | — | — | — | — | — | — |
| EBITDA | $-1.25M | $-1.77M | $-26.93M | $-67.81M | $-83.58M | $-89.09M | $-92.22M |
| EBITDA margin | — | — | — | — | — | — | — |
| EBIT | $-1.35M | $-1.88M | $-27.11M | $-68.30M | $-84.77M | $-90.60M | $-93.61M |
| Interest expense | $0.00 | $8000.00 | $172000.00 | $3.40M | — | — | — |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.35M | $-1.89M | $-27.28M | $-69.10M | $-78.63M | $-89.98M | $-89.66M |
| Net income growth (YoY) | — | -40.3% | -1344.2% | -153.3% | -13.8% | -14.4% | +0.4% |
| Profit margin | — | — | — | — | — | — | — |